Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 28, 2026
Leverage Shares 2X Long AMD Daily ETF (AMDG): A Leveraged Bet on AMD's AI Momentum

Leverage Shares 2X Long AMD Daily ETF (AMDG): A Leveraged Bet on AMD's AI Momentum

Key Takeaways

  • AMDG provides 2x daily leveraged exposure to Advanced Micro Devices (AMD), positioning it to amplify short-term moves in the AI-driven semiconductor leader.
  • The global semiconductor market is projected to exceed $1.3 trillion in revenue by 2026, fueled by AI demand, benefiting AMDG's underlying asset.
  • AMD anticipates over 60% annual data center revenue growth through 2027, driven by AI accelerators like MI400 and Helios, a key tailwind for the ETF.
  • Declining interest rates could support high-growth tech stocks like AMD, enhancing AMDG's appeal amid capex expansion by hyperscalers.
  • Leverage introduces volatility and decay risks over multi-day holds, suiting active traders rather than buy-and-hold investors.
  • Small AUM around $35 million signals potential for fund inflows if AMD momentum builds, though outflows have occurred recently.

AMDG's Strategy and Exposure

The Leverage Shares 2X Long AMD Daily ETF (AMDG) is an actively managed fund designed to deliver two times (200%) the daily percentage change of AMD stock, before fees and expenses. It achieves this through swap agreements with counterparties, alongside cash equivalents and U.S. dollars for collateral. Top holdings typically include multiple AMD swap contracts (e.g., over 100% combined weight in swaps) and treasury obligations funds like First American Funds (around 13%).

Geographically, exposure is U.S.-centric via AMD, with 100% allocation to the information technology sector, specifically semiconductors. The 0.75%-0.78% expense ratio is competitive for leveraged single-stock ETFs. Structurally, daily rebalancing ensures precise leverage but introduces compounding effects, making AMDG ideal for tactical trades on AMD's volatility rather than long-term positioning. From what I see, future performance hinges on AMD's dominance in AI GPUs and CPUs, where data center demand could drive outsized swings.

Major Catalysts on the Horizon

Upcoming AMD earnings reports, expected quarterly, will spotlight data center progress and AI chip ramps, directly impacting AMDG's daily resets. Management's guidance for multi-billion AI revenue by 2027, including MI400 series launches, could spark rallies if adoption by hyperscalers accelerates. Partnerships like the 6 GW OpenAI deal signal sustained demand.

Semiconductor supply chain shifts, including HBM4 memory transitions and new transistor architectures, may boost AMD's competitiveness versus rivals. Federal Reserve interest rate cuts would lower borrowing costs for tech capex, favoring growth names like AMD. Policy changes on AI regulation or CHIPS Act funding could influence sector flows. ETF inflows may rise with trader interest in leveraged plays, though current modest AUM suggests sensitivity to AMD momentum. I also checked this using Tickeron’s AI Pattern Search Engine to gauge potential short-term patterns in AMD.

Semiconductor Sector and Macro Outlook

The semiconductor sector outlook remains robust, with AI propelling revenue to record highs amid cloud and edge computing expansion. AMD's data center segment, now a growth engine, benefits from hyperscaler investments projected to exceed $100 billion annually by 2027 in related areas. Macro tailwinds include moderating inflation and potential rate cuts, which historically lift high-beta tech equities by easing discount rates on future earnings.

Economic growth expectations, tied to U.S. GDP forecasts, support enterprise AI adoption, while currency stability aids U.S.-focused firms. Geopolitical risks like trade tensions could pressure supply chains, but diversification efforts mitigate this for AMD. Overall, equity market trends favor AI themes, positioning AMDG to capture amplified upside from sector cycles. One thing that stands out is how these dynamics align with AMD's projected growth.

Tickeron’s Trend Prediction Engine: A Tool in My Analysis

In my research on assets like AMDG, I turn to Tickeron’s Trend Prediction Engine, an AI-powered forecasting tool that helps identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It spots developing trends, evaluates possible breakouts or reversals, and covers a wide range of tradable instruments with searchable prediction categories, historical context, and alerts for timely insights. This engine has been valuable for informing my strategies amid volatile markets, especially when tracking leveraged plays tied to AI leaders like AMD.

Long-Term Outlook and Structural Shifts

Long-term drivers for AMDG center on AMD's evolution in AI and data centers, with sustained GPU demand from cloud providers and enterprise AI adoption. Demographic shifts toward digital economies and technology adoption accelerate chip needs, while economic cycles favor semis during expansion phases. Global investment trends emphasize AI infrastructure, potentially valuing the sector in trillions. Interest rate normalization post-peak could sustain valuations for innovators like AMD. Structural changes, including open ecosystems challenging incumbents, position AMD favorably, though competition remains intense. AMDG's leverage amplifies these themes for short horizons, with the underlying index—AMD stock—tied to multi-year AI megatrends. I’m watching this closely as these trends unfold.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: AMDG

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for AMDG turns positive, indicating new upward trend

AMDG saw its Momentum Indicator move above the 0 level on September 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator turned positive. In 26 of the 26 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AMDG just turned positive on September 04, 2026. Looking at past instances where AMDG's MACD turned positive, the stock continued to rise in 14 of 14 cases over the following month. The odds of a continued upward trend are 90%.

AMDG moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AMDG crossed bullishly above the 50-day moving average on September 18, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +6.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMDG advanced for three days, in 108 of 114 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 105 of 110 cases where AMDG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMDG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

AMDG broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily levered investment results, before fees and expenses, of two times (200%) of the daily percentage change of the common stock of AMD. The fund is an actively managed ETF. It invests at least 80% of its net assets (plus borrowings for investment purposes) in swap agreements, that, in combination, provide 200% daily leveraged exposure to AMD, consistent with the fund’s investment objective. The fund is non-diversified.
View a ticker or compare two or three
AMDG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
United States
Phone
N/A
Web
www.ThemesETFs.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
Leverage Shares 2X Long AMD Daily ETF (AMDG): A Leveraged Bet on AMD's AI Momentum